Filing Details

Accession Number:
0001209191-17-041635
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-23 16:08:02
Reporting Period:
2017-06-21
Filing Date:
2017-06-23
Accepted Time:
2017-06-23 16:08:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610876 Jeffrey Chodakewitz C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp Gmda, Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-21 5,157 $96.87 127,668 No 4 M Direct
Common Stock Disposition 2017-06-21 5,157 $132.87 122,511 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-06-21 5,157 $0.00 5,157 $96.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,594 2024-07-14 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.
  2. The option vests in 16 quarterly installments from 7/15/2014.